Risk of Cesarean Delivery for Women with Obesity Using a Standardized Labor Induction Protocol

Abstract

Objective We aimed to determine the risk of cesarean among women with obesity undergoing labor induction within a prospective trial that utilized a standardized labor protocol.

Study Design This was a secondary analysis of a randomized trial of induction methods. Term (≥37 weeks) women with intact membranes undergoing induction with an unfavorable cervix (Bishop's score ≤6 and dilation ≤2 cm) were included. The trial utilized a labor protocol that standardized induction and active labor management, with recommendations for interventions at particular time points. Only women with a recorded body mass index (BMI) at prenatal care start were included in this analysis. The primary outcome was cesarean delivery compared between obese (≥30 kg/m²) and nonobese (<30 kg/m²) women. Indication for cesarean was also evaluated.

Results A total of 465 women were included: 207 (44.5%) obese and 258 (55.5%) nonobese. Women with obesity had a higher risk of cesarean compared with women without obesity (33.3 vs. 23.3%, p = 0.02), even when adjusting for parity, weight change over pregnancy, and indication for induction (adjusted relative risk [aRR] = 1.79, 95% confidence interval [CI]: [1.34–2.39]). Compared with women without obesity, women with obesity had a higher risk of failed induction (47.8 vs. 26.7%, p = 0.01) without a difference in arrest of active phase (p = 0.39), arrest of descent (p = 0.95) or fetal indication (p = 0.32), despite adherence to a standardized labor protocol.

Conclusion Compared with women without obesity, women with obesity undergoing an induction are at increased risk of cesarean, in particular a failed induction, even within the context of standardized induction management. As standardized practices limit provider variation in labor management, this study may support physiologic differences in labor processes secondary to obesity.

Key Points

• Even with a standardized induction protocol, women with obesity are at higher risk of cesarean.

• In particular, women with obesity are at increased risk of cesarean for failed induction.

• These findings support a possible biologic relationship between obesity and failed induction.

Keywords

obesity - induction of labor - cesarean delivery - failed induction - labor protocol

Publikationsverlauf

Eingereicht: 08. Oktober 2020

Angenommen: 17. Juni 2021

Artikel online veröffentlicht:
19. Juli 2021

• References

• 1 ACOG practice bulletin no 156: obesity in pregnancy. Obstet Gynecol 2015; 126 (06) e112-e126
• 2 Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19 (07) 1644-1646
• 3 Anderson NH, McCowan LM, Fyfe EM. et al; SCOPE Consortium. The impact of maternal body mass index on the phenotype of pre-eclampsia: a prospective cohort study. BJOG 2012; 119 (05) 589-595
• 4 Salihu HM, Dunlop AL, Hedayatzadeh M, Alio AP, Kirby RS, Alexander GR. Extreme obesity and risk of stillbirth among black and white gravidas. Obstet Gynecol 2007; 110 (03) 552-557
• 5 Kominiarek MA, Vanveldhuisen P, Hibbard J. et al; Consortium on Safe Labor. The maternal body mass index: a strong association with delivery route. Am J Obstet Gynecol 2010; 203 (03) 264.e1-264.e7
• 6 Marshall NE, Guild C, Cheng YW, Caughey AB, Halloran DR. Maternal superobesity and perinatal outcomes. Am J Obstet Gynecol 2012; 206 (05) 417.e1-417.e6
• 7 Ellis JA, Brown CM, Barger B, Carlson NS. Influence of maternal obesity on labor induction: a systematic review and meta-analysis. J Midwifery Womens Health 2019; 64 (01) 55-67
• 8 Roloff K, Peng S, Sanchez-Ramos L, Valenzuela GJ. Cumulative oxytocin dose during induction of labor according to maternal body mass index. Int J Gynaecol Obstet 2015; 131 (01) 54-58
• 9 Wolfe KB, Rossi RA, Warshak CR. The effect of maternal obesity on the rate of failed induction of labor. Am J Obstet Gynecol 2011; 205 (02) 128.e1-128.e7
• 10 Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol 2016; 128 (06) 1357-1364
• 11 O'Driscoll K, Foley M, MacDonald D. Active management of labor as an alternative to cesarean section for dystocia. Obstet Gynecol 1984; 63 (04) 485-490
• 12 López-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med 1992; 326 (07) 450-454
• 13 Frigoletto Jr. FD, Lieberman E, Lang JM. et al. A clinical trial of active management of labor. N Engl J Med 1995; 333 (12) 745-750
• 14 Peaceman AM, Socol ML. Active management of labor. Am J Obstet Gynecol 1996; 175 (02) 363-368
• 15 Gerhardstein LP, Allswede MT, Sloan CT, Lorenz RP. Reduction in the rate of cesarean birth with active management of labor and intermediate-dose oxytocin. J Reprod Med 1995; 40 (01) 4-8
• 16 Spong CY, Berghella V, Wenstrom KD, Mercer BM, Saade GR. Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol 2012; 120 (05) 1181-1193
• 17 Moynihan AT, Hehir MP, Glavey SV, Smith TJ, Morrison JJ. Inhibitory effect of leptin on human uterine contractility in vitro. Am J Obstet Gynecol 2006; 195 (02) 504-509
• 18 Jie Zhang, Kendrick A, Quenby S, Wray S. Contractility and calcium signaling of human myometrium are profoundly affected by cholesterol manipulation: implications for labor?. Reprod Sci 2007; 14 (05) 456-466
• 19 Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54 (09) 1847-1856
• 20 Falcão-Pires I, Castro-Chaves P, Miranda-Silva D, Lourenço AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012; 17 (15,16): 880-889
• 21 Barrichon M, Hadi T, Wendremaire M. et al. Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells. Br J Pharmacol 2015; 172 (12) 2974-2990
• 22 Mumtaz S, AlSaif S, Wray S, Noble K. Inhibitory effect of visfatin and leptin on human and rat myometrial contractility. Life Sci 2015; 125: 57-62
• 23 O'Brien M, Earley P, Morrison JJ, Smith TJ. Ghrelin in the human myometrium. Reprod Biol Endocrinol 2010; 8: 55
• 24 Lim R, Barker G, Riley C, Lappas M. Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells. Reprod Sci 2013; 20 (08) 957-967
• 25 Hermann M, Le Ray C, Blondel B, Goffinet F, Zeitlin J. The risk of prelabor and intrapartum cesarean delivery among overweight and obese women: possible preventive actions. Am J Obstet Gynecol 2015; 212 (02) 241.e1-241.e9